Posted:
1/12/2026, 5:58:22 AM
Location(s):
Cambridge, Massachusetts, United States ⋅ Massachusetts, United States
Experience Level(s):
Senior
Field(s):
Operations & Logistics
Workplace Type:
Hybrid
Company Overview:
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
Beam is seeking a highly talented and motivated Senior Directory, Gene Therapy Operations (Apheresis) leader to join our growing Commercial Patient Operations team. The Senior Director, Gene Therapy Operations will be responsible for leading Gene Therapy Operations, Apheresis team- the team responsible for 1) treatment center onboarding, training and qualification. 2) Patient Scheduling and Coordination for Apheresis and Drug Product Delivery. 3) Cell collection optimization support. 4) Drug Product storage, thawing, and administration support. The leader will be responsible for defining the strategy and scope and building their team, leading treatment center activation and patient coordination. This leader and their team must have a patient-centric and customer-focused approach to drive commercial launch readiness and execution for Beam’s lead asset, ristocel, an ex vivo autologous hematopoietic stem cell-based gene therapy for the treatment of severe sickle cell disease (SCD). This is a high impact role for Beam’s potential first product commercialization. The successful candidate plays a critical role in building and establishing commercial operations readiness for the company.
Responsibilities:
Qualifications:
The salary range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, education, scope of job, internal comparisons, and market data.
Website: https://beamtx.com/
Headquarter Location: Cambridge, Massachusetts, United States
Employee Count: 501-1000
Year Founded: 2017
IPO Status: Public
Last Funding Type: Post-IPO Equity
Industries: Biotechnology ⋅ Genetics ⋅ Medical ⋅ Therapeutics